| Title |
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
|
|---|---|
| Published in |
New England Journal of Medicine, June 2018
|
| DOI | 10.1056/nejmoa1804710 |
| Pubmed ID | |
| Authors |
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Peter M Ravdin, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, Jeffrey L Berenberg, Jeffrey Abrams, George W Sledge |
X Demographics
The data shown below were collected from the profiles of 912 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 250 | 27% |
| Spain | 51 | 6% |
| United Kingdom | 43 | 5% |
| Italy | 41 | 4% |
| Canada | 34 | 4% |
| Mexico | 20 | 2% |
| Japan | 16 | 2% |
| France | 14 | 2% |
| Brazil | 11 | 1% |
| Other | 97 | 11% |
| Unknown | 335 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 606 | 66% |
| Scientists | 146 | 16% |
| Practitioners (doctors, other healthcare professionals) | 138 | 15% |
| Science communicators (journalists, bloggers, editors) | 20 | 2% |
| Unknown | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,304 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1304 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 206 | 16% |
| Other | 143 | 11% |
| Student > Ph. D. Student | 113 | 9% |
| Student > Bachelor | 104 | 8% |
| Student > Master | 100 | 8% |
| Other | 255 | 20% |
| Unknown | 383 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 468 | 36% |
| Biochemistry, Genetics and Molecular Biology | 129 | 10% |
| Agricultural and Biological Sciences | 62 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 38 | 3% |
| Engineering | 30 | 2% |
| Other | 137 | 11% |
| Unknown | 440 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2893. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2024.
All research outputs
#2,378
of 25,713,737 outputs
Outputs from New England Journal of Medicine
#164
of 32,648 outputs
Outputs of similar age
#23
of 343,835 outputs
Outputs of similar age from New England Journal of Medicine
#2
of 276 outputs
Altmetric has tracked 25,713,737 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,648 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,835 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 276 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.